DARK Classics in Chemical Neuroscience: Methamphetamine

Thomas J. Abbruscato, Paul C. Trippier

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Methamphetamine has the second highest prevalence of drug abuse after cannabis, with estimates of 35 million users worldwide. The (S)-(+)-enantiomer is the illicit drug, active neurostimulant, and eutomer, while the (R)-(-)-enantiomer is contained in over the counter decongestants. While designated a schedule II drug in 1970, (S)-(+)-methamphetamine is available by prescription for the treatment of attention-deficit disorder and obesity. The illicit use of (S)-(+)-methamphetamine results in the sudden "rush" of stimulation to the motivation, movement, pleasure, and reward centers in the brain, caused by rapid release of dopamine. In this review, we will provide an overview of the synthesis, pharmacology, adverse effects, and drug metabolism of this widely abused psychostimulant that distinguish it as a DARK classic in Chemical Neuroscience.

Original languageEnglish (US)
Pages (from-to)2373-2378
Number of pages6
JournalACS Chemical Neuroscience
Volume9
Issue number10
DOIs
StatePublished - Oct 17 2018

Fingerprint

Methamphetamine
Neurosciences
Enantiomers
Pharmaceutical Preparations
Nasal Decongestants
Pleasure
Street Drugs
Cannabis
Attention Deficit Disorder with Hyperactivity
Reward
Metabolism
Substance-Related Disorders
Prescriptions
Motivation
Dopamine
Brain
Appointments and Schedules
Obesity
Pharmacology
Therapeutics

Keywords

  • Methamphetamine
  • drug of abuse
  • psychoactive
  • stimulant

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

DARK Classics in Chemical Neuroscience : Methamphetamine. / Abbruscato, Thomas J.; Trippier, Paul C.

In: ACS Chemical Neuroscience, Vol. 9, No. 10, 17.10.2018, p. 2373-2378.

Research output: Contribution to journalArticle

Abbruscato, Thomas J. ; Trippier, Paul C. / DARK Classics in Chemical Neuroscience : Methamphetamine. In: ACS Chemical Neuroscience. 2018 ; Vol. 9, No. 10. pp. 2373-2378.
@article{f36a2d68a4db46cd8924d8b354c5faca,
title = "DARK Classics in Chemical Neuroscience: Methamphetamine",
abstract = "Methamphetamine has the second highest prevalence of drug abuse after cannabis, with estimates of 35 million users worldwide. The (S)-(+)-enantiomer is the illicit drug, active neurostimulant, and eutomer, while the (R)-(-)-enantiomer is contained in over the counter decongestants. While designated a schedule II drug in 1970, (S)-(+)-methamphetamine is available by prescription for the treatment of attention-deficit disorder and obesity. The illicit use of (S)-(+)-methamphetamine results in the sudden {"}rush{"} of stimulation to the motivation, movement, pleasure, and reward centers in the brain, caused by rapid release of dopamine. In this review, we will provide an overview of the synthesis, pharmacology, adverse effects, and drug metabolism of this widely abused psychostimulant that distinguish it as a DARK classic in Chemical Neuroscience.",
keywords = "Methamphetamine, drug of abuse, psychoactive, stimulant",
author = "Abbruscato, {Thomas J.} and Trippier, {Paul C.}",
year = "2018",
month = "10",
day = "17",
doi = "10.1021/acschemneuro.8b00123",
language = "English (US)",
volume = "9",
pages = "2373--2378",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - DARK Classics in Chemical Neuroscience

T2 - Methamphetamine

AU - Abbruscato, Thomas J.

AU - Trippier, Paul C.

PY - 2018/10/17

Y1 - 2018/10/17

N2 - Methamphetamine has the second highest prevalence of drug abuse after cannabis, with estimates of 35 million users worldwide. The (S)-(+)-enantiomer is the illicit drug, active neurostimulant, and eutomer, while the (R)-(-)-enantiomer is contained in over the counter decongestants. While designated a schedule II drug in 1970, (S)-(+)-methamphetamine is available by prescription for the treatment of attention-deficit disorder and obesity. The illicit use of (S)-(+)-methamphetamine results in the sudden "rush" of stimulation to the motivation, movement, pleasure, and reward centers in the brain, caused by rapid release of dopamine. In this review, we will provide an overview of the synthesis, pharmacology, adverse effects, and drug metabolism of this widely abused psychostimulant that distinguish it as a DARK classic in Chemical Neuroscience.

AB - Methamphetamine has the second highest prevalence of drug abuse after cannabis, with estimates of 35 million users worldwide. The (S)-(+)-enantiomer is the illicit drug, active neurostimulant, and eutomer, while the (R)-(-)-enantiomer is contained in over the counter decongestants. While designated a schedule II drug in 1970, (S)-(+)-methamphetamine is available by prescription for the treatment of attention-deficit disorder and obesity. The illicit use of (S)-(+)-methamphetamine results in the sudden "rush" of stimulation to the motivation, movement, pleasure, and reward centers in the brain, caused by rapid release of dopamine. In this review, we will provide an overview of the synthesis, pharmacology, adverse effects, and drug metabolism of this widely abused psychostimulant that distinguish it as a DARK classic in Chemical Neuroscience.

KW - Methamphetamine

KW - drug of abuse

KW - psychoactive

KW - stimulant

UR - http://www.scopus.com/inward/record.url?scp=85054647995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054647995&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.8b00123

DO - 10.1021/acschemneuro.8b00123

M3 - Article

C2 - 29602278

AN - SCOPUS:85054647995

VL - 9

SP - 2373

EP - 2378

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 10

ER -